Table 1 Comparison of major clinico-pathological factors between NSCLC patients with or without bone metastasis
Characteristics | Bone metastasis (n = 45)n (%) | Non-bone metastasis (n = 60)n (%) | P value |
|---|---|---|---|
Gender | |||
Male | 28 (62.2) | 37 (61.7) | 0.954 |
Female | 17 (37.8) | 23 (38.3) | |
Age (mean ± SD) (yr.) | 55.8 ± 12.1 | 57.4 ± 7.2 | 0.398 |
Histopathology | |||
Adenocarcinoma | 39 (86.7) | 50 (83.5) | 0.567 |
Non-adenocarcinoma | 6 (13.3) | 10 (16.7) | |
Stage | |||
IIIa | 33 (73.3) | 53 (86.7) | 0.048 |
IIIb | 12 (26.7) | 7 (13.3) | |
Adjuvant chemotherapy | |||
Yes | 30 (66.7) | 46 (76.7) | 0.828 |
No | 15 (33.3) | 14 (23.3) | |